диссертации / 62
.pdf341
383. Successful percutaneous treatment of infected necrosis of the body of the pancreas associated with segmental disruption of the main pancreatic duct / J. Gmeinwieser [et al.] // Gastrointest. Endosc. – 2000. – Vol. 52. – P. 413–415.
384.Surgery in the treatment of acute pancreatitis – open pancreatic necrosectomy / J. Werner [et al.] // Scand. J. Surg. – 2005. – Vol. 94, № 2. – P. 130–134.
385.Surgical management of severe pancreatitis including sterile necrosis / W. Hartvig [et al.] // J. Hepatobil. Pancreat. Surg. – 2002. – Vol. 9. – P. 429–435.
386.Surgical technic in acute necrotizing pancreatitis / J. Funovics [et al.] // Langenbecks Arch. Surg. – 1988. – Vol. 373, № 5. – P. 313–317.
387.Surgical treatment for severe acute pancreatitis: extent and surgical control of necrosis determine outcome / P. Gotzinger [et al.] // World J. Surg. – 2002. – Vol. 26, № 4. – P. 474–478.
388.Surgical treatment of severe acute pancreatitis: timing of operation is crucial for survival / P. Gotzinger [et al.] // Surg. Infect. – 2003. – Vol. 4, № 2. – P. 205–211.
389.Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery / Y. Haga [et al.] // Crit. Care Med. – 1997. – Vol. 25, № 12. – P. 1994–2000.
390.Talreja, J.P. Endotherapy for pancreatic necrosis and abscess: endoscopic drainage and necrosectomy / J.P. Talreja, M.Kahaleh // J. Hepatobil. Pancreat. Surg. – 2009. – Vol.16, № 5. – P. 605–612.
391.Talukdar, R. Early management of severe acute pancreatitis / R. Talukdar, S. Swaroop Vege // Curr. Gastroenterol. Rep. – 2011. – Vol. 13, № 2. – P. 123–130.
392.The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults / W.A. Knaus [et al.] // Chest. – 1991. – Vol. 100, № 6.
– P. 1619–1636.
393.The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis / B. Rau [et al.] // Intensive Care Med. – 2000. – Vol. 26, suppl. 2. – S159–
342
394.The Cochrane database of systematic reviews. – London: BMJ Publishing Group and Update Software, 1995. – 260 p.
395.The pancreatitis classification of Marseille: Rome / H. Sarles [ et al. ] // Scand. J. Gastroenterol. – 1988. – Vol. 24. – P. 651–652.
396.The potential role of procalcitonin and interleukin / B. Rau [et al.] // Gut . – 1997. – Vol. 41, № 6. – P. 832–840.
397.The results of severe acute pancreatitis treatment with continuous regional arterial infusion of protease inhibitor and antibiotic: a randomized controlled study / M. Piascik [et al.] // Pancreas. – 2010. – Vol. 39, № 6. – P. 863–867.
398.The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review / R. Mofidi [et al.] // Surgery. – 2009. – Vol. 146, № 1. – P. 72–81.
399.Tellado, J.M. Prevention of infection following severe acute pancreatitis / J.M. Tellado // Curr. Opin. Crit. Care. – 2007. – Vol. 13, № 4. – P. 416–420.
400.Timing and impact of infections in acute pancreatitis / M.G. Besselink [et al.] // Br. J. Surg. – 2009. – Vol. 96, № 3. – Р. 267–273.
401.Timing of surgical intervention in necrotizing pancreatitis / M.G. Besselink [et al.] // Arch. Surg. – 2007. – Vol. 142, № 12. – P. 1194–1201.
402.Toh, S.K.C. A prospective audit against national standards of the presentation and management of acute pancreatitis in the South of England / S.K.C. Toh, S. Phillips, C.D. Johnson // Gut. – 2000. – Vol. 46. – P. 239–243.
403.Toouli, J. Guidelines for the management of acute pancreatitis / J. Toouli // J. Gastroenterol. Hepatol. – 2002. – Vol. 17, suppl. – P. 15–39.
404.Total enteral nutrition in prevention of pancreatic necrotic infection in severe acute pancreatitis / X.M. Wu [et al.] // Pancreas. – 2010. –Vol. 39, № 2. – P. 248–251.
405.Toward an update of the atlanta classification on acute pancreatitis: review of new and abandoned terms / T.L. Bollen [et al.] // Pancreas. – 2007. – Vol. 35, № 2. – Р. 107–113.
343
406.Treatment of abdominal compartment syndrome in severe acute pancreatitis patients with traditional Chinese medicine / M.J. Zhang [et al.] // World J. Gastroenterol. – 2008. – Vol. 14, № 22. – P. 3574–3478.
407.Treatment outcome of selective digestive decontamination and enteral nutrition in patients with severe acute pancreatitis / H. Sawa [et al.] // J. Hepatobil. Pancreat. Surg. – 2007. – Vol. 14, № 5. – P. 503–508.
408. Treatment strategy for acute pancreatitis / K.Wada [et al.] // J. Hepatobil. Pancreat. Surg. – 2009. – Vol. 16, № 6. – P. 850–857.
409.Triester, S.L. Prognostic factors in acute pancreatitis / S.L. Triester // J. Clin. Gastroenterol. – 2002. – Vol. 34. – P. 167–176.
410.Trypsinogen activation peptides / D. Heath [et al.] // Gut. – 1994. – Vol. 35. – P. 1311–1315.
411.Uhl, W. International Association of Pancreatology guidelines for the surgical management of acute pancreatitis / W. Uhl // Pancreatology. – 2007. – № 2. – P. 565–
412.UK guidelines for the management of acute pancreatitis / UK Working Party on Acute Pancreatitis // Gut. – 2005. – Vol. 54, suppl. 3. – P. 1–9.
413.Ultrasound-guided percutaneous drainage may decrease the mortality of severe acute pancreatitis / X. Ai [et al.] // J. Gastroenterol. – 2010. – Vol. 45, № 1. – P. 77–85.
414.Use of an artificial neural network to predict length of stay in acute pancreatitis / W.E. Pofahl [et al.] // Am. Surg. – 1998. – Vol. 64, № 9. – P. 868–872.
415.Vaishnavi, C. Enteral nutrition in severe acute pancreatitis / C. Vaishnavi, R.P. Doley // JOP. – 2009. – Vol. 10, № 2. – Р. 157–162.
416.Value of routine clinical tests in predicting the development of infected pancreatic necrosis in severe acute pancreatitis / Z. Dambrauskas [et al.] // Scand. J. Gastroenterol. – 2007. – Vol. 42, № 10. – P. 1256–1264.
417.Vege, S.S. Organ failure as an indicator of severity of acute pancreatitis: time to revisit the Atlanta classification / S.S. Vege, S.T. Chari // Gastroenterology. – 2005. – Vol. 128, № 4. – P. 1133–1135.
344
418.Werner, J. Infectious complications in necrotizing pancreatitis / J. Werner, M.W. Buchler // Zentralbl. Chir. – 2007. – Vol. 132, № 5. – P. 433–437.
419.Werner, J. Management of acute pancreatitis: from surgery to interventional intensive care / J. Werner // Gut. – 2005. – Vol. 54, № 53. – P. 426–436.
420.Wilson, C. Prediction of outcome in acute pancreatitis: a comparative study of APACHE-II, clinical assessment and multiple factor scoring systems / C.Wilson // Br. J. Surg. – 1990. – Vol. 77. – P.1260–1264.
421.Windsor, J.A. Infected pancreatic necrosis: drain first, but do it better/ J.A. Windsor // HPB (Oxford). – 2011. – Vol. 13, № 6. – P. 367–368.
422.Wu, X.N. Current concept of pathogenesis of severe acute pancreatitis / X.N. Wu // World J. Gastroenterol. – 2000. – Vol. 6, № 1. – P. 32–36.
423.Wu, X.N. Guidelines for treatment of severe acute pancreatitis / X.N. Wu // Hepatobil. Pancreat. Dis. Int. – 2002. – Vol. 1, № 3. – P. 446–451.
424.Wu, B.U. Update in acute pancreatitis / B.U. Wu, D.L. Conwell // Curr. Gastroenterol. Rep. – 2010. – Vol. 12, № 2. – Р. 83–90.
425.Wyncoll, D.L. The management of severe acute necrotising pancreatitis: an evidence-based review of the literature / D.L. Wyncoll // Intensive Care Med. –1999. – Vol. 25, № 2. – Р. 146–156.
426.Yoldas, O. Prediction of clinical outcomes using artificial neural networks for patients with acute biliary pancreatitis / O. Yoldas, M. Koc, N. Karakose // Pancreas. – 2008. – Vol. 36, № 1. – P. 90–92.
345
ПРИЛОЖЕНИЯ
Приложение 1
Индивидуальная карта №________
Дата поступления__________/_____ выписки__________/_____. Проведено к/дней________, до операции_______. ФИО________________________________________________________ Год рождения__________(_____) Пол: м / ж Адрес:____________________________________________________________________________________________________
Диа-
гноз:________________________________________________________________________________________________________
____________________________________________________________________________________________________________
____________________________________________________________________________________________________________
____________________________________________________________________________________________________________
____________________________________________________________________________________________
Анамнез:____________________________________________________________________________________________________
________________________________________________________________________________________
_______________________________________________________________________ госпитализ.- впервые/повторно Употребление алкоголя, жирной пищи, травма поджелудочной железы; ЖКБ, сахарный диабет в анамнезе Срок с момента заболевания___________Проводилось ли лечение до поступления_______Полноценность_______
Операции: лапаротомии, люмботомии_________________________________________________________________
____________________________________________________________________________________________________________
________________________________________________________________________________________
__________________________________________________________________________________________________
перевязки под наркозом_____________________________________________________________________________
лапароско-
пии_________________________________________________________________________________________________________
_______________________________________________________________________________
пункции под УЗ-контролем___________________________________________________________________________
__________________________________________________________________________________________________
ЭРПХГ, ЭПСТ, ФГДС (БДС)___________________________________________________________________________
____________________________________________________________________________________________________________
________________________________________________________________________________________
Перевод в ОАРИТ
Показатели При пост 1 сутки 2 сутки 3 - 7 8 - 11 12 - 15 16 - 30 >30 сут.
Выр. болевой синдром
Рвота
Словесная реакция
Двигательная реакция
Реакция глаз
ИВЛ
Кожные симптомы
Температура тела
ЧД
ЧСС
САД
ДАД
ЦВД
Мышечный дефанс
Пальпир. инфильтрат
Вздутие живота
Диурез
Стул
ЭКГ: ишемия миокарда
Посев крови на стерил.
-выпота из бр. полости
-выпота из сал. сумки
КТ__________________________________________________________________________________________________________
________________________________________________________________________________________
346
Лабораторные пок - ли |
При пост |
1 сутки |
2 сутки |
3 - 7 |
8 - 11 |
12 - 15 |
16 - 30 |
>30 сут. |
||
Лейкоциты |
(109/л) |
|
|
|
|
|
|
|
|
|
- промиелоциты |
(%) |
|
|
|
|
|
|
|
|
|
- миелоциты |
|
(%) |
|
|
|
|
|
|
|
|
- юные |
|
(%) |
|
|
|
|
|
|
|
|
- палочкоядерные |
(%) |
|
|
|
|
|
|
|
|
|
- сегментоядерные |
(%) |
|
|
|
|
|
|
|
|
|
ЛИИ |
|
|
|
|
|
|
|
|
|
|
Индекс агрессии |
|
|
|
|
|
|
|
|
|
|
Эритроциты |
(1012/л) |
|
|
|
|
|
|
|
|
|
Гемоглобин |
|
(г/л) |
|
|
|
|
|
|
|
|
Ht |
|
(%) |
|
|
|
|
|
|
|
|
СОЭ |
(мм/ч) |
|
|
|
|
|
|
|
|
|
Глюкоза |
(мМоль/л) |
|
|
|
|
|
|
|
|
|
Общий белок |
|
(г/л) |
|
|
|
|
|
|
|
|
- альбумины |
|
|
|
|
|
|
|
|
|
|
- глобулины |
|
|
|
|
|
|
|
|
|
|
АЛТ |
|
(Е/л) |
|
|
|
|
|
|
|
|
АСТ |
|
(Е/л) |
|
|
|
|
|
|
|
|
Общий билирубин |
|
|
|
|
|
|
|
|
|
|
- связанный |
|
|
|
|
|
|
|
|
|
|
- свободный (мкМоль/л) |
|
|
|
|
|
|
|
|
||
ЩФ |
|
|
|
|
|
|
|
|
|
|
ГГТП |
|
|
|
|
|
|
|
|
|
|
ЛДГ |
|
(Е/л) |
|
|
|
|
|
|
|
|
СРБ |
|
|
|
|
|
|
|
|
|
|
ПКТ |
|
|
|
|
|
|
|
|
|
|
Мочевина |
(мМоль/л) |
|
|
|
|
|
|
|
|
|
Креатинин (мкМоль/л) |
|
|
|
|
|
|
|
|
||
Амилаза крови |
|
(Е/л) |
|
|
|
|
|
|
|
|
Амилаза мочи |
(мг/с. л) |
|
|
|
|
|
|
|
|
|
Ca2+ |
|
|
|
|
|
|
|
|
|
|
Na+ |
|
|
|
|
|
|
|
|
|
|
K+ |
|
|
|
|
|
|
|
|
|
|
FiO2 |
|
(%) |
|
|
|
|
|
|
|
|
pH |
|
|
|
|
|
|
|
|
|
|
pCO2 |
mmHg |
|
|
|
|
|
|
|
|
|
PaO2 |
|
mmHg |
|
|
|
|
|
|
|
|
HCO3- |
(мМоль/л) |
|
|
|
|
|
|
|
|
|
BE |
(мМоль/л) |
|
|
|
|
|
|
|
|
|
УЗИ-динамика |
|
|
|
|
|
|
|
|
|
|
Лечение: раннее____________________________________________________________________________________
базис_____________________________________________________________________________________
усиленное_________________________________________________________________________________
На какие сутки развилось нагноение___________________________________________________________________
Антибиотики, применявшиеся до его развития___________________________________________________________
__________________________________________________________________________________________________
Другие осложнения (на какие сутки)____________________________________________________________________
__________________________________________________________________________________________________